Shatter® (hexaflumuron) and Intrepid® (methoxyfenozide) were evaluated as alternative treatment for controlling bed bugs. Both products were tested at 50, 100, 200, 500, 1,000 and 5,000 ppm prepared in acetone and topically applied to laboratory-reared susceptible strain bed bugs that were maintained under ambient temperature at approximately 60% humidity. Shatter® had three replicates per concentration (treatment) and ten 3rd instar nymphs were treated with each concentration, while Intrepid® had five replicates per concentration and ten 5th instar nymphs were treated with each concentration. Bed bugs were treated topically with a 1μL droplet of desired concentrations on the thorax. Mortality was recorded daily for up to 14 and 18 d for Shatter® and Intrepid®, respectively. For Intrepid®, the average number of molts, as well as mortality were calculated and compared to the control replicates. For Shatter®, mortality was calculated for each time interval. Abbott's formula was used to correct for control mortality. An analysis of variance or Student's t-test was performed for any statistically significant differences between concentrations.
Shatter® provided greater mortality when compared to Intrepid®. Intrepid® at 50-5,000 ppm caused only 0-4% mortality and there were no differences in the rate or frequency of ecdysis at 18 d after exposure. Shatter® at 500 and 1,000 ppm provided 48% mortality and it also yielded 30% mortality at the lowest 50 ppm dose. There was no clear dose response. 
